United Capital Financial Advisors LLC Invests $590,000 in Cabot Corporation $CBT

United Capital Financial Advisors LLC bought a new stake in shares of Cabot Corporation (NYSE:CBT) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,495 shares of the specialty chemicals company’s stock, valued at approximately $590,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of CBT. Rothschild Investment LLC lifted its position in Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 259 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new position in Cabot during the second quarter valued at $33,000. Global Retirement Partners LLC increased its position in Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 466 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 364 shares during the period. Finally, Danske Bank A S bought a new stake in shares of Cabot in the 3rd quarter worth about $38,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Insider Activity

In related news, CEO Sean D. Keohane sold 134,895 shares of the stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares of the company’s stock, valued at $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 229,597 shares of company stock valued at $19,646,746 in the last ninety days. 3.08% of the stock is currently owned by insiders.

Cabot Stock Down 1.1%

Shares of CBT opened at $82.72 on Tuesday. The firm has a fifty day moving average price of $87.46 and a 200-day moving average price of $81.29. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $4.27 billion, a P/E ratio of 23.30, a P/E/G ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $94.53.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping the consensus estimate of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same quarter last year, the firm posted $1.90 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts expect that Cabot Corporation will post 6.35 earnings per share for the current year.

Cabot Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is currently 53.24%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CBT shares. Mizuho lifted their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. JPMorgan Chase & Co. boosted their target price on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. UBS Group cut their target price on Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $89.00.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.